Clinical Trial Update: OPTIMOX1 in Chinese mCRC Patients [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update for OPTIMOX1 in Chinese patients with metastatic colorectal cancer, with the trial status listed as UNKNOWN. The documen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Nanjing Medical University | Conditions: Colorectal Cancer | Phase 4 | Status: UNKNOWN